×
Integer Holdings Price to Free Cash Flow Ratio 2010-2024 | ITGR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Integer Holdings price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
View More
Integer Holdings Price to Free Cash Flow Ratio 2010-2024 | ITGR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Integer Holdings price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$216B
Thermo Fisher Scientific (TMO)
$205.7B
Alcon (ALC)
$44.2B
Edwards Lifesciences (EW)
$44.1B
IDEXX Laboratories (IDXX)
$37.1B
DexCom (DXCM)
$34.9B
IQVIA Holdings (IQV)
$34.2B
Mettler-Toledo (MTD)
$27.3B
Waters (WAT)
$22.6B
STERIS (STE)
$21.7B
SONOVA HOLDING (SONVY)
$19.3B
Hologic (HOLX)
$14.4B
Fresenius Medical Care AG KGaA (FMS)
$13.5B
Penumbra (PEN)
$11.7B
Sysmex ADR (SSMXY)
$11.5B
Globus Medical (GMED)
$11.5B
Masimo (MASI)
$9.5B
Glaukos (GKOS)
$8.7B
Teleflex (TFX)
$8.1B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$3.4B
Veracyte (VCYT)
$3.2B
Nihon Kohden (NHNKY)
$2.7B
LivaNova (LIVN)
$2.6B
TransMedics (TMDX)
$2.5B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.1B
Integra LifeSciences Holdings (IART)
$1.7B
Alphatec Holdings (ATEC)
$1.5B
Pulse Biosciences (PLSE)
$1.2B